Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bioinformatics and protein design.

Roman A Laskowski1, A W Edith Chan

  • 1European Bioinformatics Institute, Hinxton, Cambridge, CB10 1SD, UK.

Current Pharmaceutical Biotechnology
|December 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quinoline-Based Neuropilin‑1 Antagonists Exhibit a Pure Antagonist Profile and Block Vascular Endothelial Growth Factor-Induced Pain.

ACS pharmacology & translational science·2025
Same author

Deciphering the Coevolutionary Dynamics of L2 β-Lactamases via Deep Learning.

Journal of chemical information and modeling·2024
Same author

In silico prediction of heme binding in proteins.

The Journal of biological chemistry·2024
Same author

The effects of pathogenic and likely pathogenic variants for inherited hemostasis disorders in 140 214 UK Biobank participants.

Blood·2023
Same author

A small-molecule PI3Kα activator for cardioprotection and neuroregeneration.

Nature·2023
Same author

Mapping the Constrained Coding Regions in the Human Genome to Their Corresponding Proteins.

Journal of molecular biology·2022
Same journal

Comparative Phytochemical Characterization and Antibacterial Activity of Ethanol and Aqueous Extracts of Moringa peregrina and Moringa oleifera against Multidrug-Resistant Bacteria.

Current pharmaceutical biotechnology·2026
Same journal

Unveiling Aptamers for Targeted Tumour Therapies and Detection: Systematic Evolution of Ligands by Exponential Enrichment (SELEX) Technology in Oncology.

Current pharmaceutical biotechnology·2026
Same journal

Nanosuspensions-Based Dry Powder Inhalers for Pulmonary Delivery of Hydrophobic Natural Products: Formulation Strategies, Efficacy, and Challenges.

Current pharmaceutical biotechnology·2026
Same journal

Bone Marrow Mesenchymal Stem Cell-Derived Exosomes Accelerate Diabetic Rat Wound Healing by Inhibiting Pyroptosis through the NLRP3/Caspase-1/GSDMD Pathway.

Current pharmaceutical biotechnology·2026
Same journal

Cyperotundone Regulates Polo-like Kinase 1-mediated Glycolysis to Inhibit the Proliferation of Breast Cancer Cells.

Current pharmaceutical biotechnology·2026
Same journal

Risk Factor Analysis and Nomogram for Predicting 28-day in-hospital Mortality in ICU Patients with Liver Necrosis.

Current pharmaceutical biotechnology·2026
See all related articles

Protein therapeutics, including de novo designed molecules, are a promising future in medicine. Bioinformatics and knowledge of protein structures are key to designing novel protein drugs with specific functions.

Area of Science:

  • Biochemistry
  • Drug Development
  • Bioinformatics

Background:

  • Drug development traditionally focused on small molecule therapeutics.
  • Advances in recombinant protein technology are enabling the use of proteins as therapeutics.
  • Existing protein drugs include naturally occurring, engineered, and gene therapy-derived proteins.

Purpose of the Study:

  • To review the role of bioinformatics in the de novo design of protein therapeutics.
  • To highlight the potential of custom-designed proteins for future medical applications.

Main Methods:

  • Leveraging extensive bioinformatics knowledge from experimentally determined protein structures.
  • Utilizing computational approaches for de novo protein design.
  • Analyzing successful de novo protein structures available in the Protein Data Bank.

Related Experiment Videos

Main Results:

  • De novo protein design is a viable approach for creating novel therapeutics.
  • Bioinformatics plays a crucial role in tailoring protein structure and function.
  • Several de novo protein structures have been successfully designed and documented.

Conclusions:

  • Carefully designed protein therapeutics represent a genuine prospect for the future of medicine.
  • Continued advancements in understanding protein folding and structure will further enhance de novo design capabilities.